FCGR2A and systemic lupus erythematosus: Dysregulation of FcγR-mediated pathways has been linked to autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.